RANDOX LIPOPROTEIN— 510(k) K011568
Substantially EquivalentRandox Laboratories, Ltd.
FDA 510(k) clearance K011568 for RANDOX LIPOPROTEIN, Substantially Equivalent on 2001-09-28. Applicant: Randox Laboratories, Ltd.. Device class: 2.
Clearance details
- Applicant
- Randox Laboratories, Ltd.
- Product code
- Code JIS
- Device class
- Class 2
- Regulation
- 21 CFR 862.1150
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Crumlin, GB
Recent devices under product code JIS
view allMore clearances from Randox Laboratories, Ltd.
view allRecalls naming K011568
K-number listed on FDA's recall record- Z-1017-2025 — Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403
- Z-1018-2025 — Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757
Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K011568.
Data sourced from openFDA. This site is unofficial and independent of the FDA.